Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE: 600867)
Health Care · Pharmaceuticals · CN
CN¥7.88
+0.25% today · -7.8% 1Y
Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE: 600867) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.30B and employs 3,354 people.
Over the last twelve months the share price has lost 7.8%, trading between 7.16 and 10.67.
Tweenvest scores Tonghua Dongbao Pharmaceutical Co., Ltd. across four factors: quality 80/100, value 70/100, growth 32/100, dividend 89/100. Its strongest factor is dividend.
600867 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.30B
- Revenue (TTM)
- $456.76M
- P/E
- 11.97
- EPS
- 0.66
- Dividend yield
- 3.81%
- Beta (5Y)
- 0.14
- 52-week high
- CN¥10.67
- 52-week low
- CN¥7.16
- Avg volume (3M)
- —
- Shares outstanding
- 1.96B
- Employees
- 3,354
- Next earnings
- —
About Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. is a Chinese enterprise primarily engaged in the research, development, manufacturing, and commercialization of pharmaceutical products. These therapeutics are designed to address diabetes and various cardiovascular conditions within the Chinese market. Its operations are structured across two distinct divisions: pharmaceuticals and building materials. The company's extensive pharmaceutical portfolio features prominent insulin analogues, including insulin glargine, insulin aspart, and insulin lispro. Furthermore, it offers a range of antidiabetic medications, oral hypoglycemic drugs, and medical devices such as Gan Shulin pens and blood glucose meters. Tonghua Dongbao also maintains a strategic partnership with Adocia. Established in 1985, the company is headquartered in Tonghua, China.
- ISIN
- CNE000000H87
- Founded
- 1985
- Listed since
- Aug 24, 1994
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aether Industries LimitedNSEI: AETHER | $2.40B | Rs1,748.10 | +4.68% |
| Jamjoom Pharmaceuticals Factory CompanySASE: 4015 | $2.39B | SR128.00 | +0.95% |
| Harmony Biosciences Holdings, Inc.NasdaqGM: HRMY | $2.35B | $39.02 | -3.13% |
| HUTCHMED (China) LimitedAIM: HCM | $2.33B | £2.03 | -2.87% |
| Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858 | $2.29B | CN¥14.81 | +1.16% |
| Prestige Consumer Healthcare Inc.NYSE: PBH | $2.28B | $49.21 | +2.03% |
| Bausch Health Companies Inc.NYSE: BHC | $2.26B | $5.91 | -2.15% |
| ApicHope Pharmaceutical Group Co., Ltd.SZSE: 300723 | $2.24B | CN¥33.42 | +0.45% |
Figures last refreshed Oct 11, 2026.